DEC1 Loss Linked to Oesophageal Cancer Progression
Author Information
Author(s): Wong V C L, Ko J M Y, Qi R Z, Li P J, Wang L D, Li J-L, Chan Y P, Chan K W, Stanbridge E J, Lung M L
Primary Institution: University of Hong Kong
Hypothesis
Is the expression of DEC1 associated with the progression of oesophageal squamous cell carcinoma (SCC) and influenced by age and family history?
Conclusion
The study suggests that loss of DEC1 is significantly associated with lymph node metastasis and early onset of oesophageal SCC, particularly in patients with a family history of the disease.
Supporting Evidence
- DEC1 expression decreases from normal tissue to lymph node metastasis.
- Loss of DEC1 is more significant in younger patients compared to older patients.
- Patients with a family history of oesophageal SCC show significantly lower DEC1 expression.
Takeaway
This study found that a protein called DEC1 is less present in oesophageal cancer, especially in younger patients and those with family histories of the disease, which might help doctors understand and detect this type of cancer better.
Methodology
The study used tissue microarrays (TMAs) and immunohistochemical staining to analyze DEC1 expression in oesophageal SCC tissues.
Limitations
The study's findings need further validation with larger sample sizes.
Participant Demographics
{"gender":{"male":96,"female":55},"age":{"≤44":30,"45–69":86,"≥70":35}}
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website